Literature DB >> 16356999

Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: how strong is the evidence?

Bernard G Bannwarth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16356999      PMCID： PMC1315667          DOI： 10.1136/bmj.331.7530.1474

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland; Richard Logan
Journal:  BMJ       Date:  2005-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.